Resource Library
The Resource Library is a compendium of consent forms, risk management recommendations, sample documents, articles, and other risk management materials to promote ophthalmic patient safety and reduce liability. Contact riskmanagement@omic.com with questions.
Found
14
resources.
Nov 5, 2015
| Consent Form
...about Eylea. Here is more information about the warning. New tests on animals show that intravenous Eylea (given directly into the vein) may not be safe for the fetus. Eylea was recently tested on pregnant rabbits. The rabbits were given very high doses of Eylea every three days. The Eylea...
Oct 25, 2023
| Consent Form
...you have obtained informed consent. · Keep the original in the patient’s medical record. Version 10/25/23 [Your Letterhead] Informed Consent for Intravitreal Injection of Eylea®HD 8mg (aflibercept) How Eylea®HD 8mg treats your condition Because you have [Condition], your ophthalmologist, [Name], [M.D./D.O.], is recommending Eylea®HD 8mg, an anti-VEGF medication. Ophthalmologists use...
Mar 13, 2020
| Consent Form
...intravitreal injection published by a panel of experts. It also addresses the FDA warning about Avastin in more detail. Here is a link to the risk management recommendations www.omic.com/anti-VEGF-drugs-in-adults/. Informed consent for Eylea™ (aflibercept) Ophthalmologists (ophthalmologists) treat some types of eye problems with a medication called Eylea. Eylea can help...
Jun 30, 2015
| Risk Management Bulletin
There are two Eylea consent forms. Use Eylea form for all adult patients receiving Eylea. This form was revised on 03/13/2020. Ask women of child-bearing age to sign Eylea.Possible risk for the fetus. This consent form was revised on 11/5/2015. Review our risk management recommendations on the use of anti-VEGF drugs...
Feb 21, 2023
| Recommendation
...of the same indications. Age-related macular degeneration (AMD): BEOVU® (brolucizumab), Eylea® (aflibercept), Lucentis® (ranibizumab). Vabysmo® (faricimab-svao). Diabetic macular edema (DME): Eylea, Lucentis, Iluvien® (fluocinolone acetonide) and Ozurdex® (dexamethasone) are approved to treat DME. Vabysmo (faricimab-svao). Diabetic retinopathy (DR): Eylea and Lucentis are approved to treat DR. Retinal vein occlusion (RVO):...
Oct 14, 2018
| Case Study
...ophthalmologist used the needle included with the Eylea kit to puncture the dexamethasone vial after puncturing the Eylea vial. The prepackaged Avastin needle was used to puncture the dexamethasone vial and then was used again to inject the patients. Betadine and Navobay Hypochlorous solution was used to prep for the...
Mar 10, 2022
| Recommendation
...vasculosa lentis. Some infants have disease that persists despite laser. Other means of arresting ROP are thus needed. Adult patients with retinal conditions due at least in part to VEGF have been successfully treated with intravitreal injections of anti-VEGF agents such as AvastinTM (bevacizumab), MacugenTM (pegaptanib), LucentisTM (ranibizumab), and EyleaTM...
Apr 1, 2022
| Recommendation
...blood in the eye may block the path to the abnormal blood vessels. Ophthalmologists can inject a medication in the baby’s eye to treat ROP. This is called an intravitreal injection. The medication, called anti-VEGF, stops the eye from making the VEGF chemical. There are three anti-VEGF medications: Avastin, Eylea,...
Mar 9, 2023
| Consent Form
...an alternative to laser surgery, ophthalmologists can inject anti-VEGF medication into the baby’s eye to treat ROP. This is called an intravitreal injection. There are many anti-VEGF medications but the ones which are used to treat ROP include Avastin (bevacizumab), Eylea (aflibercept), and Lucentis (ranibizumab). The ophthalmologist will talk to...
Jun 30, 2015
| Risk Management Bulletin
Vascular endothelial growth factor, or VEGF, is a protein that stimulates the growth of new blood vessels. Ophthalmologists administer intravitreal anti-VEFG agents to adults for a variety of indications. These include Avastin, BEOVU, Lucentis, and Eylea. Sometimes the indication has been approved by the Food and Drug Administration (FDA), other...
Nov 5, 2015
| Consent Form
...show that drugs like Lucentis given directly into the vein may not be safe for the fetus. Two drugs called Avastin and Eylea were recently tested on pregnant rabbits. The rabbits were given very high doses of these drugs every three days. The drugs were injected directly into the vein...
Jan 1, 2023
| Recommendation
...is called an intravitreal injection. The medication, called anti-VEGF, stops the eye from making the VEGF chemical. There are three anti-VEGF medications: Avastin, Eylea, and Lucentis. The ophthalmologist will talk to you about which medication will be injected. The goal of the injection is to keep the retina attached and...
Mar 13, 2020
| Consent Form
...animals show that drugs like Lucentis given directly into the vein may not be safe for the fetus. Two drugs called Avastin and Eylea were recently tested on pregnant rabbits. The rabbits were given very high doses of these drugs every three days. The drugs were injected directly into the...
Aug 15, 2018
| Article
...plaintiffs (72%) developed endophthalmitis following cataract surgery (58) or intravitreal injections (21: Avastin 12, Eylea 5, Lucentis 3, Kenalog 1). Others filed claims after pars plana vitrectomy or PPV (13), trauma (5), systemic infections (4), and corneal transplants (3). The remaining 5 plaintiffs alleged malpractice after an IOL exchange, a...